Capitalizing a CureA free open access ebook is available upon publication. Learn more at www. luminosoa. org. Capitalizing a Cure takes readers into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. But their sticker shockthe drug was dubbed "the $1,000 a day